Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

FDA to Review Bausch + Lomb's Intraocular Lens

February 27, 2013 1:42 pm | by Mass Device | News | Comments

Eye care giant Bausch + Lomb won a date with the FDA for review of its Trulign Toric intraocular lens for improving vision in patient who have undergone cataract surgery. On April 8, 2013, the FDA's Ophthalmic Devices Panel will review clinical data and cast a vote on the Trulign Toric implant in treatment of patients with vision impairment as a result of aphakia and postoperative refractive astigmatism.

John Muir Health Pilots Early Warning System For Heart Attack Patients

February 27, 2013 12:58 pm | by The Associated Press | News | Comments

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Feb 27, 2013--Reducing the time it takes heart attack patients to receive treatment significantly increases their chances of survival and minimizes long-term damage to the heart and brain. John Muir Health’s Clinical Research Center recently began a clinical...

Mako gets a Wall Street boost as sales soar, losses narrow in 2012

February 27, 2013 11:47 am | by Mass Device | News | Comments

Surgical devices maker Mako Surgical, maker of the Rios robot-assisted surgery system, posted impressive boosts to its sales during the 4th quarter and full year of 2012. Mako saw increases in sales of its Rios system as well as the adjunct Makoplasty Total Hip Arthroplasty application.


Sonitus Medical Announces Affirmative Update Regarding Bone Conduction Oral Appliances in American Academy of Otolaryngology-Head and Neck Surgery Policy Statement on Implantable Hearing Devices

February 27, 2013 10:01 am | by The Associated Press | News | Comments

Sonitus Medical, Inc., a medical device company that manufactures the world's first and only non-surgical and removable hearing device to transmit sound via the teeth, announced today that the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) approved a policy statement on...

Cardica Updates Enrollment Progress In European Clinical Trial

February 27, 2013 9:10 am | by The Associated Press | News | Comments

Cardica, Inc. (Nasdaq: CRDC) today announced that 109 patients have been enrolled in the company's European clinical trial designed to evaluate the safety of its MicroCutter XCHANGET 30 cutting/stapling device in a variety of surgical procedures. Cardica plans to complete enrollment of 160 ...

Oncology Practices Financial Performance Insight Application Released by Altos Solutions, Inc.

February 27, 2013 9:00 am | by The Associated Press | News | Comments

PLEASANTON, Calif.--(BUSINESS WIRE)--Feb 27, 2013--Altos Solutions, Inc., developer of OncoEMR™, an oncology-specific, browser-based electronic medical record (EMR) with integrated patient portal and medical billing technology, today announced a strategic alliance with RemitDATA, Inc., a leading...

CellAegis Devices Announces Clinical Program to Use the Company's Noninvasive autoRICT Device for Chronic Remote Ischemic Conditioning (CRIC) following Acute Myocardial Infarction (AMI)

February 27, 2013 7:31 am | by The Associated Press | News | Comments

CellAegis Devices, Inc., announced today that it has received an Investigational Testing Approval (ITA) from Health Canada that allows the initiation of clinical testing in Canada of the Company's autoRICT Device for Chronic Remote Ischemic Conditioning (CRIC).  In a Canadian Institutes of...

CONMED Corporation Announces Quarterly Cash Dividend

February 27, 2013 7:01 am | by The Associated Press | News | Comments

CONMED Corporation (NASDAQ: CNMD) announced today that its Board of Directors has declared a quarterly cash dividend of $0.15 per share, payable on April 5, 2013 to all shareholders of record as of March 15, 2013. The Board expects that future cash dividends will be paid on a quarterly basis...


Syneron Beauty Introduces the me smooth At-Home Hair Removal System

February 27, 2013 6:23 am | by The Associated Press | News | Comments

Syneron Beauty Inc., a subsidiary of Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announces the launch of the me smooth, a revolutionary at-home professional hair removal device for all skin tones using Syneron's patented elos technology. ...

AdvaMed Fights to Keep User Fees Out of Sequester Cuts for FDA

February 26, 2013 4:20 pm | by Mass Device | News | Comments

The medical device industry doesn't want user fees paid by industry to be included in a series of cuts slated for the FDA's budget this week. The federal watchdog agency will have $210 million, or about 5.1% of its $4.1 billion budget, cut from its 2013 budget March 1 as a result of sequestration, the bargain between the White House and Congress.

UCLA Researchers Further Refine 'Nanovelcro' Device to Grab Single Cancer Cells from Blood

February 26, 2013 4:17 pm | by I-Micronews | News | Comments

Researchers at UCLA report that they have refined a method they previously developed for capturing and analyzing cancer cells that break away from patients' tumors and circulate in the blood. With the improvements to their device, which uses a Velcro-like nanoscale technology, they can now detect and isolate single cancer cells from patient blood samples for analysis.

NuVasive Announces First Patients in Japan Treated With the XLIF(R) Surgical Technique

February 26, 2013 4:15 pm | by The Associated Press | News | Comments

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is proud to announce that the very first eXtreme Lateral Interbody Fusion (XLIF®) procedures were performed yesterday and today at two different...

Online Tech’s Managed Cloud Protects Online Dermatology Treatment Service, NoviMedicine

February 26, 2013 2:45 pm | by The Associated Press | News | Comments

As the advancements in telemedicine and health apps for mobile devices make receiving health care easier by the day, Los Angeles-based NoviMedicine is getting into the act by building a system for board-certified dermatologists to discuss, evaluate and treat patients’ acne completely online.


Searcy Denney Scarola Barnhart & Shipley Attorney Appointed to Plaintiff's Steering Committee for Stryker Hip Implant Litigation

February 26, 2013 2:15 pm | by Bio-Medicine.Org | News | Comments

WEST PALM BEACH, Fla. , Feb. 26, 2013 /- South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA ( Searcy Denney ) announced today that C. Calvin Warriner , a shareholder at the firm, was appointed to the newly established Plaintiff's Steering Committee for the Stryker Rejuvenate and ABG II hip implant Multi-County Litigation in New Jersey . Warrin...

University of Rhode Island Researchers Use Impulse C to FPGA to Help Amputees Sit, Stand and Climb Stairs with “Smart” Artificial Legs

February 26, 2013 1:59 pm | by Impulse Accelerated Technologies | News | Comments

URI and Impulse Accelerated Technologies (one of the project sponsors) publicized results from student research to improve the live-ability of artificial legs. In this research, students created a neurally controlled artificial leg that enabled users to command it wordlessly for common challenges.

Obesity, Physical Inactivity Linked With Risk for Certain Molecular Subtype of Colorectal Cancer

February 26, 2013 1:00 pm | by AACR | News | Comments

An increasing body mass index was associated with a higher risk for colorectal cancer with a specific molecular characteristic, and inversely, physical activity was linked to a decreased risk for that same cancer, according to data published in Cancer Research, a journal of the American Association for Cancer Research.

Growing Body of Evidence Supports Use of DFINE’s Targeted Radiofrequency Ablation™ (t-RFA) for Treatment of Spinal Tumors

February 26, 2013 12:00 pm | by The Associated Press | News | Comments

SAN JOSE, Calif.--(BUSINESS WIRE)--Feb 26, 2013--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today released data presented at the 2013 Annual Symposium of the American Society of Spine Radiology (ASSR) on Feb....

STENTYS to Present Final Results From 1,000 Heart Attack Patient Study at ACC.13

February 26, 2013 11:35 am | by The Associated Press | News | Comments

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing ® Stent to treat acute myocardial infarction, announced today that results for the primary endpoint in the APPOSITION III study (MACE at one year on 1,000 STEMI patients) will be presented during ACC.13, the American College of Cardiology’s Scientific Session & Expo.

HD Medical, Inc. Hosts Launch Celebration for Newly Formed US Business Unit at ACC.13

February 26, 2013 11:28 am | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Feb 26, 2013--At the American College of Cardiology’s 62nd Annual Scientific Session & Expo, ACC.13, HD Medical, Inc. will hold “Heart & Sound” an ACC.13 Industry Event celebrating the formation of HD Medical in the US. Come rejoice with us and enjoy good...

Bacterin International Holdings, Inc. Announces ISO Certification

February 26, 2013 10:59 am | by The Associated Press | News | Comments

BELGRADE, Mont.--(BUSINESS WIRE)--Feb 26, 2013--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it has achieved ISO 13485:2003 Certification. This certification is...

HIMSS 13 Product Launch: Ciphertex Announces 24TB Portable Encrypted NAS Server for Medical Offices

February 26, 2013 10:15 am | by The Associated Press | News | Comments

LOS ANGELES--(BUSINESS WIRE)--Feb 26, 2013--Ciphertex, a leading international provider of external HHD and portable encryption network attached storage (NAS) server systems, today announced the CX-6K-MD, a 24TB portable secure NAS server capable of storing more than two million medical images....

Medtronic Gains First FDA Approval to Conduct Early Feasibility Medical Device Study

February 26, 2013 10:06 am | by The Associated Press | News | Comments

Medtronic, Inc. announced that it has received U.S. Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Medtronic Native Outflow Tract Transcatheter Pulmonary Valve (TPV). This approval represents the first-ever FDA approval of an investigational device exemption (IDE) following the new draft FDA guidance for early feasibility studies.

Quotient Biodiagnostics Raises Further $5.0 Million of Growth Finance Led by Paul Cowan and Galen Partners

February 26, 2013 9:59 am | by The Associated Press | News | Comments

EDINBURGH, Scotland & NEWTOWN, Pa.--(BUSINESS WIRE)--Feb 26, 2013--Quotient Biodiagnostics (“Quotient”), a global transfusion diagnostics group, is pleased to announce that its shareholders have invested a further $5.0 million in the company. Over the past 18 months Quotient has raised over...

FDA Advisory Panel Recommends Approval of the NeuroPace RNS® System for Medically Refractory Epilepsy

February 26, 2013 8:00 am | by The Associated Press | News | Comments

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Feb 26, 2013--NeuroPace, Inc. today announced that on February 22, 2013 the U.S. Food and Drug Administration (FDA) Neurological Devices Panel voted unanimously (11 to 0 with two abstentions) that the clinical benefits of the NeuroPace RNS System outweigh...

Brain Implants Can Reset Misfiring Circuits

February 25, 2013 3:39 pm | by Massachusetts Institute of Technology | News | Comments

A study that combined electrical stimulation of the brain with advanced imaging has shown how correcting misfiring neural circuits can lessen the symptoms of a common psychiatric disorder. A brain-pacemaker helped put out-of-sync brain circuits back on track in patients with extreme forms of obsessive-compulsive disorder.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.